Browsing: tag: BZI-AAR
Throughout the last three months, 4 analysts have evaluated Editas Medicine EDIT, offering a diverse set of opinions from bullish…
Analyst Scoreboard: 15 Ratings For Apellis Pharmaceuticals – Apellis Pharmaceuticals (NASDAQ:APLS)
Across the recent three months, 15 analysts have shared their insights on Apellis Pharmaceuticals APLS, expressing a variety of opinions…
6 analysts have expressed a variety of opinions on Moelis MC over the past quarter, offering a diverse set of…
Decoding 5 Analyst Evaluations For Petco Health and Wellness – Petco Health and Wellness (NASDAQ:WOOF)
Across the recent three months, 5 analysts have shared their insights on Petco Health and Wellness WOOF, expressing a variety…
In the latest quarter, 8 analysts provided ratings for Nevro NVRO, showcasing a mix of bullish and bearish perspectives. The…
9 analysts have shared their evaluations of Blue Owl Cap OWL during the recent three months, expressing a mix of…
During the last three months, 10 analysts shared their evaluations of Lennox Intl LII, revealing diverse outlooks from bullish to…
During the last three months, 5 analysts shared their evaluations of Puma Biotechnology PBYI, revealing diverse outlooks from bullish to…
In the latest quarter, 35 analysts provided ratings for Walmart WMT, showcasing a mix of bullish and bearish perspectives. The…
Breaking Down Floor & Decor Hldgs: 13 Analysts Share Their Views – Floor & Decor Hldgs (NYSE:FND)
13 analysts have expressed a variety of opinions on Floor & Decor Hldgs FND over the past quarter, offering a…